N4BP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.441400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.663200E-01
Normal-vs-Stage2
8.808400E-01
Normal-vs-Stage3
3.475800E-01
Normal-vs-Stage4
4.284200E-01
Stage1-vs-Stage2
1.362600E-01
Stage1-vs-Stage3
5.679000E-01
Stage1-vs-Stage4
1.987440E-01
Stage2-vs-Stage3
2.018200E-01
Stage2-vs-Stage4
1.396820E-01
Stage3-vs-Stage4
1.402400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.203400E-01
Normal-vs-AfricanAmerican
7.901000E-01
Normal-vs-Asian
6.670600E-01
Caucasian-vs-AfricanAmerican
9.252800E-01
Caucasian-vs-Asian
5.504800E-01
AfricanAmerican-vs-Asian
7.966200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.418600E-01
Normal-vs-Female
8.342000E-01
Male-vs-Female
9.854200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.087400E-01
Normal-vs-Age(41-60Yrs)
6.907400E-01
Normal-vs-Age(61-80Yrs)
6.594000E-01
Normal-vs-Age(81-100Yrs)
3.396200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.007200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.570600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.609420E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.800000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.165680E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.567800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.709000E-01
Normal-vs-Daily Drinker
5.707800E-01
Normal-vs-Weekly Drinker
5.332800E-01
Normal-vs-Occasional Drinker
3.748200E-01
Normal-vs-Social Drinker
7.244600E-01
Non Drinker-vs-Daily Drinker
5.846800E-01
Non Drinker-vs-Weekly Drinker
7.952200E-01
Non Drinker-vs-Occasional Drinker
8.237300E-04
Non Drinker-vs-Social Drinker
2.108000E-02
Daily Drinker-vs-Weekly Drinker
8.514400E-01
Daily Drinker-vs-Occasional Drinker
9.983600E-03
Daily Drinker-vs-Social Drinker
1.034780E-01
Weekly Drinker-vs-Occasional Drinker
1.463860E-02
Weekly Drinker-vs-Social Drinker
1.027180E-01
Occasional Drinker-vs-Social Drinker
3.102600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.217600E-02
Normal-vs-Grade 2
1.744200E-03
Normal-vs-Grade 3
8.414700E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.528400E-02
Grade 1-vs-Grade 3
2.443900E-03
Grade 1-vs-Grade 4
6.217600E-02
Grade 2-vs-Grade 3
8.629700E-02
Grade 2-vs-Grade 4
1.744200E-03
Grade 3-vs-Grade 4
8.414700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.632600E-01
Normal-vs-NonDiabetic
8.865800E-01
Diabetic-vs-NonDiabetic
1.119570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.752200E-01
Normal-vs-NoPancreatitis
7.746400E-01
Pancreatitis-vs-NoPancreatitis
5.398600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.689200E-01
Normal-vs-N1
8.771600E-01
N0-vs-N1
6.287600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.071800E-01
Normal-vs-TP53-NonMutant
4.876200E-01
TP53-Mutant-vs-TP53-NonMutant
1.776480E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
